Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - SELLAS Life Sciences Group, Inc. | b84103exv21w1.htm |
| EX-31.1 - EX-31.1 - SELLAS Life Sciences Group, Inc. | b84103exv31w1.htm |
| 10-K - FORM 10-K - SELLAS Life Sciences Group, Inc. | b84103e10vk.htm |
| EX-32.1 - EX-32.1 - SELLAS Life Sciences Group, Inc. | b84103exv32w1.htm |
| EX-31.2 - EX-31.2 - SELLAS Life Sciences Group, Inc. | b84103exv31w2.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
RXi Pharmaceuticals Corporation
Worcester, MA
Worcester, MA
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3
(No.333-167025) and Form S-8 (Nos. 333-153847) and 333-151154) of RXi Pharmaceuticals Corporation
of our report dated April 15, 2011, relating to the financial statements which appear in this Form
10-K.
/s/ BDO USA, LLP
Boston, MA
Boston, MA
April 15, 2011